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Children born from mothers positive for autoantibodies
against SSA/Ro and/or anti-SSB/La ribonucleoproteins
may develop heart conduction tissue damage resulting
in atrioventricular block and/or transient skin rash, liver
enzyme abnormalities and anaemia/thrombocytopenia.
Additional transient electrocardiographic abnormalities
(sinus bradycardia, QT interval prolongation) have been
reported. Such clinical and laboratory manifestations are
included in the so-called Neonatal Lupus Syndromes,
independently whether the mother is suffering from a
systemic autoimmune disease or is totally asymptomatic.
The prevalence of the congenital heart block is around
2%, of neonatal lupus rash around 20%, while laboratory
abnormalities in asymptomatic babies can be detected in
up to 30% of cases. The risk of recurrence of complete
heart block is almost ten times higher in the following
pregnancies. Most of the mothers are asymptomatic
at delivery and are identified only by the birth of an
affected child. Their longterm outcome is generally more
reassuring than previously assumed and arthralgias and
xerophtalmia are the commonest symptoms.
A standard therapy for heart blocks detected in utero
is still matter of investigation, although fluorinated corti-
costeroids have been reported to be effective on myocardi-
tic signs when present. Serial echocardiograms and
obstetric sonograms, performed at least every two weeks
starting from the 16 weeks’ gestation, are recommended in
anti-Ro/SSA positive pregnant women: the goal is to
detect early fetal abnormalities, that might precede com-
plete atrioventricular block and that might be a target of
preventive therapy.
Transplacental passage of maternal anti-SSA/SSB IgG
is thought to be pivotal in inducing tissue damage.
However, the discordant appearance of the syndrome in
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